Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
01:36:40 EDT Sun 31 May 2026
Enter Symbol
or Name
USA
CA



News last 24 hour(s) - 30 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2026-05-30 22:45U:ELEKNews ReleaseAs Global Markets Discover Elektros, Microcap and Penny Stock Investors Are Beginning To Take Notice of a Growing EV Patent Technology and Lithium Mining Company
2026-05-30 22:15U:FUNNews ReleaseSIX FLAGS FIESTA TEXAS UNLEASHES WEREWOLF GORGE, THE WORLD'S LONGEST FAMILY LAUNCH ROLLER COASTER
2026-05-30 22:00U:ELEKNews ReleaseGlobal EV Charging Patent Update: Elektros Inc. Continues To Advance and Protect Its Intellectual Property as EV Infrastructure Opportunities Expand Worldwide
2026-05-30 21:15U:ELEKNews ReleaseGlobal Microcap Investors Are Discovering a Rare Diamond in the Rough
2026-05-30 20:42U:AUMMFNews ReleaseResults of Annual General Meeting
2026-05-30 17:24U:BAYZFNews ReleaseASCO 2026: Bayer Shares New Findings for NUBEQA(TM) (darolutamide) Regarding Cognitive Decline in Men with Advanced Prostate Cancer Compared to Enzalutamide in Phase II ARACOG Head-to-Head Trial
2026-05-30 17:24U:BAYRYNews ReleaseASCO 2026: Bayer Shares New Findings for NUBEQA(TM) (darolutamide) Regarding Cognitive Decline in Men with Advanced Prostate Cancer Compared to Enzalutamide in Phase II ARACOG Head-to-Head Trial
2026-05-30 14:30U:WHWKNews ReleaseWhitehawk Therapeutics Presents Real-World Analysis Confirming SEZ6 as a Highly Expressed, Clinically Relevant Target for SCLC and Other Neuroendocrine Tumors at ASCO 2026
2026-05-30 14:30U:PGENNews ReleasePrecigen Presents New Long-Term Durability Data for PAPZIMEOS, Recently Granted Seven-Year Market Exclusivity, Demonstrating Complete Responses Beyond 4 Years
2026-05-30 14:30U:EIKNNews ReleaseEikon Therapeutics Presents Data on Clinical-Stage Programs at the 2026 Annual Meeting of the American Society of Clinical Oncology
2026-05-30 14:15U:BNTXNews ReleaseGlobal Data for BioNTech and Bristol Myers Squibb's PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial
2026-05-30 12:03U:BWLPNews ReleaseBW LPG Enters Into Agreement for Eight 90'cbm Panamax Newbuildings with Hyundai Heavy Industries
2026-05-30 12:00U:MIRMNews ReleaseMirum Pharmaceuticals Announces New Data from Rare Liver Disease Programs Presented at the EASL International Liver Congress 2026
2026-05-30 11:15U:MLYSNews ReleaseMineralys Therapeutics Presents New Data from the Phase 3 Launch-HTN Trial of Lorundrostat in Participants with Hypertension and Chronic Kidney Disease at European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)
2026-05-30 10:00U:EXELNews ReleaseExelixis Announces Results from Subgroup Analysis of Phase 3 CABINET Pivotal Trial Evaluating CABOMETYX(TM) (cabozantinib) in Non-Functional and Functional Neuroendocrine Tumors at ASCO 2026
2026-05-30 08:30U:TEMNews ReleaseTempus Launches the PRECISION Challenge, a National Program Opening Its Foundation Model Work to the Broader Research Community
2026-05-30 08:00U:VCYTNews ReleaseENZAMET Trial Shows Veracyte's Decipher Prostate Test Identifies Which Patients Benefit from Adding Chemotherapy in Metastatic Prostate Cancer
2026-05-30 08:00U:TEMNews ReleaseTempus Introduces 'Preview': Bridging the Critical Time Gap Between Diagnostic Order and Definitive Results
2026-05-30 08:00U:SMMTNews ReleaseEncouraging Global Phase II Ivonescimab Data in First-Line Metastatic Colorectal Cancer Presented at ASCO 2026
2026-05-30 08:00U:REPLNews ReleaseReplimune Presents 3-Year Landmark Overall Survival Analysis from IGNYTE Clinical Trial During Oral Presentation at the 2026 American Society of Clinical Oncology Annual Meeting
2026-05-30 08:00U:PFENews ReleaseTALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer
2026-05-30 08:00U:MOLNNews ReleaseMolecular Partners Holds Presentations at ASCO and SNMMI 2026 on DLL3-Targeting Radio-DARPin MP0712, Now Dosing Patients in Phase 1
2026-05-30 08:00U:INCYNews ReleaseIncyte's Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi(TM)/Minjuvi(TM)) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL
2026-05-30 08:00U:IMTXNews ReleaseImmatics Presents Clinical Activity of IMA203CD8 PRAME Cell Therapy in Hard-to-Treat Gynecologic Cancers at 2026 ASCO Annual Meeting
2026-05-30 08:00U:IMNMNews ReleaseImmunome Announces Detailed Phase 3 RINGSIDE Data for Varegacestat in Adults with Progressing Desmoid Tumors at the 2026 ASCO Annual Meeting
2026-05-30 08:00U:GRALNews ReleaseGRAIL Reports Full Results From NHS-Galleri Trial Demonstrating Substantial Reduction in Stage IV Cancer Diagnoses at 2026 ASCO Annual Meeting
2026-05-30 08:00U:COGTNews ReleaseCogent Biosciences Announces Detailed Clinical Data from PEAK Phase 3 Trial with Bezuclastinib in Combination with Sunitinib in Gastrointestinal Stromal Tumors (GIST) at 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
2026-05-30 07:00U:SMXWNews ReleaseSMX and the Age of Parity: Recycled Plastic Is No Longer a Sustainability Choice-It's an Economic Imperative
2026-05-30 07:00U:SMXNews ReleaseSMX and the Age of Parity: Recycled Plastic Is No Longer a Sustainability Choice-It's an Economic Imperative
2026-05-30 04:14U:VVIVFNews ReleaseReplenish Nutrients: Market Has Yet to Price in the H2 2026 Capacity and Licensing Inflection